Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03799133
Other study ID # ISM_VC_01_17
Secondary ID 17-1025
Status Completed
Phase N/A
First received
Last updated
Start date September 26, 2018
Est. completion date December 28, 2019

Study information

Verified date January 2020
Source Critical Perfusion Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evaluate the safety and effectiveness of the XL trend measured by Florence (Critical Perfusion Inc, Palo Alto, California) in the prediction of morbimortality of Mexican patients post-operated of elective cardiovascular surgery.

Hypothesis: 1. The gastric reactance measurement (XL) correlates with the morbimortality (postoperatory shock, excessive bleeding, vasoplegic syndrome and death) and with the risk predictors (APACHE II, STS, SOFA, and EUROSCORE II) with patients post-operated of elective cardiac surgery. 2. It is possible to identify the cut-off point of the values of the gastric reactance (XL) as a predictive tool of morbimortality in patients post-operated of elective cardiac surgery. 3. The gastric reactance (XL) is a safe measurement to patients undergoing cardiac surgery.


Description:

A maximum of 35 patients with age greater or equal to 18 years with elective surgery (valvular surgery, revascularization, or a combination of both) that comply with the inclusion/exclusion criteria of this protocol will be enrolled.

Investigational device: Florence (Gastric Impedance Spectrometer System or ISMO). Comparative with Risk scales SOFA, APACHE II, STS, Euroscore II, hemodynamic variables, lactate and mixed venous saturation.

The Florence catheter will be placed at the beginning of the surgery and up to 72 hours in ICU.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date December 28, 2019
Est. primary completion date December 28, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Women and men within an age equal or greater than 18 years old.

- Subjects scheduled to an elective cardiac surgery for valvular surgery, revascularization or a combination of both.

- Subjects compliant with the indication to be placed a floating pulmonary artery catheter.

- Marks results previous to surgery: STS mortality risk equal or greater than 6% of the day before or Euro Score II with a mortality risk equal or greater than 6% or left ventricle ejection fraction (LVEF/FEVI) less than 45% (patients with cardiac failure or right ventricle dysfunction or a combination of both), tricuspid annular plane systolic excursion (TAPSE) less than 17 mm, peak systolic velocity of tricuspid lateral ring measured by Tissue Doppler (LVOT/TSVI) less than 0.1 m/s; patient with elective surgery of: aortic and mitral valve replacement or aortic and mitral valve replacement + tricuspid valve plasty or aortic valve replacement + mitral valve plasty or mitral valve replacement + tricuspid valve plasty or aortic, mitral and tricuspid valve replacement or aortic valve replacement + tricuspid valve plasty or double valve replacement (any combination) + revascularization or aortic valve replacement + revascularization + mitral valve plasty.

- Subject is not enrolled in another investigational protocol.

- Informed consent has been signed of acceptance by the subject before study procedures.

- Subject in sinus rhythm before surgery.

Exclusion Criteria:

- Subjects with records of recent digestive tube bleeding (last 30 days).

- Paraplegic or hemiplegic subjects.

- Subjects with congenital background (interauricular communication, ventricular atrial channel, coarctation of the aorta, persistent arterial duct, pulmonary stenosis, ventricular septal defect, tetralogy of fallot, total or partial anomalous pulmonary venous drainage, transposition of the great vessels, tricuspid atresia, arterial trunk, etc).

- Maxillofacial malformation.

- Catheter placement failure.

- Known pregnancy or discovered pregnancy after admission (before surgery).

- Woman in breastfeeding period.

- Subjects not compliant with clinical indication of nasogastric catheter placement or contraindicated to place a nasogastric catheter.

- Subjects with an implanted pacemaker or permanent defibrillator.

- Medication supply that impedes contact between Florence catheter and the gastric mucosa (barrier effect) like sucralfate, aluminum hydroxide, bismuth subsalicylate, magaldrate, etc.

Study Design


Intervention

Device:
Florence device
The Florence catheter will be placed at the beginning of the surgery and up to 72 hours in ICU.

Locations

Country Name City State
Mexico Instituto Nacional de Cardiología Ignacio Chávez Tlalpan Ciudad De México

Sponsors (5)

Lead Sponsor Collaborator
Critical Perfusion Inc. Alandra Medical SAPI de CV, Gerbera Capital, Instituto Nacional de Cardiologia Ignacio Chavez, National Council of Science and Technology, Mexico

Country where clinical trial is conducted

Mexico, 

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation between gastric reactance (XL) and morbimortality and risk predictors Multivariate analysis to observe variability between different events according to data distribution to determine how is affecting the risk scales, hemodynamic variables, lactate and mixed venous oxygen saturation, morbidity and mortality with central gastric reactance (XL). 72 hours
Primary Sensibility and specificity of the collected variables ROC curves will be calculated to determine sensibility and specificity of the variables. 72 hours
Primary Adverse events tracing with the use of Florence catheter Serious Adverse Device Effects and Adverse Events assessment to evaluate device safety. 30 days
Secondary Correlations between XL measurements and medication Multivariate analysis to observe variability between different events according to data distribution to determine how is affecting XL with amines, proton-pump inhibitors, and anesthesia medications. 72 hours
Secondary Correlations between laboratory parameters and XL Multivariate analysis to observe variability between different events according to data distribution to determine how is affecting XL with laboratory parameters. 72 hours
Secondary Usability of Florence device in a real environment. Questionnaire for the nurse and/or the physician regarding the use of Florence device at the Operating Room and Intensive Care Unit. 72 hours
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Completed NCT02241109 - Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity N/A
Completed NCT01676727 - ADVANCE Direct Aortic Study
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Completed NCT00721136 - Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation N/A
Recruiting NCT05014750 - Frailty of Elderly With Valvular Heart Disease and the Short Term Adverse Events
Recruiting NCT05044338 - Study on Standard Evaluation System and Optimal Treatment Path of Senile Valvular Heart Disease
Recruiting NCT05015829 - Diagnostic Impact of Low-dose Dobutamine Echocardiography in Low-flow Low-gradient Aortic Stenosis
Recruiting NCT05078619 - Percutaneous Coronary Intervention Before Transcatheter Aortic Valve Implantation N/A
Recruiting NCT06307262 - European Registry of Transcatheter Repair for Tricuspid Regurgitation
Completed NCT01624870 - CoreValve Advance-II Study: Prospective International Post-market Study
Completed NCT05708690 - Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery Phase 4
Recruiting NCT03797820 - Multicenter Registry Study of Aortic Valve Stenosis in Zhejiang Elderly(Mrs AVS)
Recruiting NCT06077721 - Milrinone on Right Ventricular Strain in Cardiac Surgery
Not yet recruiting NCT04632914 - Effect of Trunk Stabilizing Exercises on Patients With Median Sternotomy After Heart Valve Surgery N/A
Completed NCT01477151 - Randomized Isoflurane and Sevoflurane Comparison in Cardiac Surgery Phase 4
Terminated NCT03590730 - Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy
Recruiting NCT06204783 - Real-time Pressure Volume Loop Monitoring as a Guide for Enhanced Understanding of Changes in Elemental Cardiovascular Physiology During Therapeutic Strategies Aiming for Hemodynamic Optimization. Cohort II: Structural Heart Interventions (PLUTO-II)
Enrolling by invitation NCT05775354 - Reviving Early Diagnosis of Cardiovascular Disease in the Utrecht Health Project N/A
Not yet recruiting NCT04301648 - Impact in Quality of Care of the "STructural heARt NURSE" as New Interventional Cardiology Nursing Role in Spain. N/A

External Links